Phase II Study Exploring Five Fractions of Post-operative Radiation Therapy in Head and Neck Cancer
NCT05648461 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2022-12-13
Summary
The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers. The present study is a non -randomized phase II study that will enroll 50 patients and test feasibility of 30 Gy in 5 fractions of the primary disease and ipsilateral level I-III disease.
Conditions
Interventions
- RADIATION
-
Five fraction of post operative radiotherapy
Target volume will include tumor bed \& ipsilateral level I-III levels.
Sponsors & Collaborators
-
All India Institute of Medical Sciences
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-02-29
- Completion
- 2026-02-01
Countries
- India
Study Locations
More Related Trials
-
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx
NCT04538547 ·Status: UNKNOWN ·Phase: NA
-
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00054054 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Re-Irradiation for Recurrent Head and Neck Cancer
NCT03217188 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00265941 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
NCT01693718 ·Status: COMPLETED ·Phase: PHASE2
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer
NCT00426504 ·Status: COMPLETED ·Phase: NA
-
Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk
NCT00937612 ·Status: TERMINATED ·Phase: NA
-
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
NCT01467115 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of APG-157 in Head and Neck Cancer
NCT05312710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC
NCT05053737 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy
NCT03700905 ·Status: UNKNOWN ·Phase: PHASE3
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer
NCT04862455 ·Status: TERMINATED ·Phase: PHASE2
-
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
NCT00462735 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034 ·Status: UNKNOWN ·Phase: NA
-
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
NCT00956007 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer
NCT04834349 ·Status: WITHDRAWN ·Phase: PHASE2
-
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
NCT05172245 ·Status: RECRUITING ·Phase: PHASE1
-
Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)
NCT00188318 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
NCT00006051 ·Status: COMPLETED ·Phase: PHASE2
-
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
NCT00646659 ·Status: TERMINATED ·Phase: PHASE2
-
InductionChemo-Radio-Antibody-Treatment
NCT01181401 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
NCT03247712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2